New study offers hope for extending ovarian healthspan and function

A woman’s ovaries are like a factory where eggs grow and produce hormones that regulate everything from menstruation and pregnancy to bone density and mood.

FORE raises funding to expedite plixorafenib development

Plixorafenib demonstrated favourable antitumour activity in patients with BRAF-altered advanced central nervous system tumours. Credit: SciPro/Shutterstock.com. US-based precision oncology company FORE Biotherapeutics has raised $75m

August 24, 2023

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) – Psychedelic Alpha

NEW YORK and BERLIN, Aug. 08, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

August 8, 2023

Blood test may aid early detection of Parkinson’s and guide treatment strategies

To date Parkinson’s disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.